Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, November 16, 2022
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
Salim Syed Maintained (UBX) at Strong Buy with Decreased Target to $12 on, Nov 16th, 2022
Salim Syed of Mizuho, Maintained "Unity Biotechnology, Inc." (UBX) at Strong Buy with Decreased Target from $80 to $12 on, Nov 16th, 2022.
Salim has made no other calls on UBX in the last 4 months.
There are 3 other peers that have a rating on UBX. Out of the 3 peers that are also analyzing UBX, 0 agree with Salim's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Salim
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $10 on, Wednesday, November 9th, 2022
- Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $36 on, Wednesday, November 2nd, 2022
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $80 on, Monday, August 15th, 2022
